LGALS9 and hepatocellular carcinoma: Thus, the galectin-9 expression level was correlated with cellular adhesion and aggregation in melanoma cells [16], oral squamous cell carcinomas [17], breast cancer [18] and hepatocellular carcinoma (HCC) [19].